Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

NeuroOne Medical Technologies Corporation - Common Stock (NQ:NMTC)

4.530 +0.320 (+7.60%)
Streaming Delayed Price Updated: 1:35 PM EDT, May 18, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 23,559
Open 4.200
Bid (Size) 4.500 (100)
Ask (Size) 4.530 (9,900)
Prev. Close 4.210
Today's Range 4.200 - 4.590
52wk Range 3.274 - 6.960
Shares Outstanding 12,000,585
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
NeuroOne Medical Technologies (NASDAQ:NMTC) Fiscal Q2 Revenue Surges 72% But Misses Estimates, Shares Dip ↗
Via Chartmill
News headline image
NeuroOne Reports Fiscal Q2 2026 Financial Results and Provides Corporate Business Update
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Economy

Performance

YTD
-11.4%
-11.4%
1 Month
-6.4%
-6.4%
3 Month
+11.2%
+11.2%
6 Month
+11.5%
+11.5%
1 Year
+14.2%
+14.2%

More News

Read More
NeuroOne Reports Fiscal Q2 2026 Financial Results and Provides Corporate Business Update
Via TheNewswire.com
Topics Economy
NeuroOne(R) Regains Compliance With Nasdaq Listing Requirement
Via TheNewswire.com
News headline image
NeuroOne(R) Regains Compliance With Nasdaq Listing Requirement
Via NewMediaWire
NeuroOne(R) Issues Shareholder Letter and Provides Corporate Update
Via TheNewswire.com
News headline image
NeuroOne(R) Announces Chief Financial Officer Succession Plan
Via NewMediaWire
Topics Retirement
NeuroOne(R) Announces Chief Financial Officer Succession Plan
Via TheNewswire.com
Topics Retirement
News headline image
NeuroOne(R) to Report Second Quarter Fiscal Year 2026 Financial Results on Tuesday, May 12 at 8:30 a.m. Eastern Time
Via NewMediaWire
Topics Earnings
NeuroOne(R) to Report Second Quarter Fiscal Year 2026 Financial Results on Tuesday, May 12 at 8:30 a.m. Eastern Time
Via TheNewswire.com
Topics Earnings
NeuroOne(R) Advances Brain Drug Delivery Platform Through Collaboration With University of Minnesota
Via TheNewswire.com
News headline image
NeuroOne(R) Advances Brain Drug Delivery Platform Through Collaboration With University of Minnesota
Via NewMediaWire
News headline image
NeuroOne(R) Medical Technologies Announces Reverse Stock Split to Regain Nasdaq Compliance
Via NewMediaWire
NeuroOne(R) Medical Technologies Announces Reverse Stock Split to Regain Nasdaq Compliance
Via TheNewswire.com
News headline image
NeuroOne(R) Medical Technologies Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Via NewMediaWire
NeuroOne(R) Medical Technologies Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Via TheNewswire.com
News headline image
NeuroOne(R) Successfully Completes Limited Market Release of OneRF(R) Trigeminal Nerve Ablation System
Via NewMediaWire
NeuroOne(R) Successfully Completes Limited Market Release of OneRF(R) Trigeminal Nerve Ablation System
Via TheNewswire.com
News headline image
NeuroOne(R) Announces Publication of Clinical Experience With Its OneRF(R) sEEG-Guided Radiofrequency Ablation Technology
Via NewMediaWire
NeuroOne(R) Announces Publication of Clinical Experience With Its OneRF(R) sEEG-Guided Radiofrequency Ablation Technology
Via TheNewswire.com
News headline image
NeuroOne(R) to Present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference March 17, 2026 at 1:20 p.m. Eastern Time
Via NewMediaWire
NeuroOne(R) to Present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference March 17, 2026 at 1:20 p.m. Eastern Time
Via TheNewswire.com
News headline image
NeuroOne(R) Issues Shareholder Letter and Provides Corporate Update
Via NewMediaWire
News headline image
NeuroOne(R) Appoints David Wambeke as Chief Business Officer; Concurrently Completes Insider Purchase of 1 Million Shares
Via NewMediaWire
NeuroOne(R) Appoints David Wambeke as Chief Business Officer; Concurrently Completes Insider Purchase of 1 Million Shares
Via TheNewswire.com

Frequently Asked Questions

Is NeuroOne Medical Technologies Corporation - Common Stock publicly traded?
Yes, NeuroOne Medical Technologies Corporation - Common Stock is publicly traded.
What exchange does NeuroOne Medical Technologies Corporation - Common Stock trade on?
NeuroOne Medical Technologies Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for NeuroOne Medical Technologies Corporation - Common Stock?
The ticker symbol for NeuroOne Medical Technologies Corporation - Common Stock is NMTC on the Nasdaq Stock Market
What is the current price of NeuroOne Medical Technologies Corporation - Common Stock?
The current price of NeuroOne Medical Technologies Corporation - Common Stock is 4.530
When was NeuroOne Medical Technologies Corporation - Common Stock last traded?
The last trade of NeuroOne Medical Technologies Corporation - Common Stock was at 05/18/26 01:35 PM ET
What is the market capitalization of NeuroOne Medical Technologies Corporation - Common Stock?
The market capitalization of NeuroOne Medical Technologies Corporation - Common Stock is 54.36M
How many shares of NeuroOne Medical Technologies Corporation - Common Stock are outstanding?
NeuroOne Medical Technologies Corporation - Common Stock has 54M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.